GB0414194D0 - Medicinal use of receptor ligands - Google Patents
Medicinal use of receptor ligandsInfo
- Publication number
- GB0414194D0 GB0414194D0 GB0414194A GB0414194A GB0414194D0 GB 0414194 D0 GB0414194 D0 GB 0414194D0 GB 0414194 A GB0414194 A GB 0414194A GB 0414194 A GB0414194 A GB 0414194A GB 0414194 D0 GB0414194 D0 GB 0414194D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- receptor ligands
- medicinal use
- medicinal
- ligands
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0414194A GB0414194D0 (en) | 2004-06-24 | 2004-06-24 | Medicinal use of receptor ligands |
US11/597,839 US20080119456A1 (en) | 2004-05-29 | 2005-05-30 | Substituted Thiazoleacetic Acid as Crth2 Ligands |
JP2007513845A JP2008503447A (en) | 2004-05-29 | 2005-05-30 | Substituted thiazole acetic acid as CRTH2 ligand |
PCT/EP2005/005882 WO2005116001A1 (en) | 2004-05-29 | 2005-05-30 | Substituted thiazoleacetic as crth2 ligands |
CA002568742A CA2568742A1 (en) | 2004-05-29 | 2005-05-30 | Substituted thiazoleacetic as crth2 ligands |
EP05748037A EP1758874A1 (en) | 2004-05-29 | 2005-05-30 | Substituted thiazoleacetic acids as crth2 ligands |
BRPI0511671-6A BRPI0511671A (en) | 2004-05-29 | 2005-05-30 | thiazolacetic substituted as crth2 ligands |
MXPA06013924A MXPA06013924A (en) | 2004-05-29 | 2005-05-30 | Substituted thiazoleacetic as crth2 ligands. |
AU2005247610A AU2005247610A1 (en) | 2004-05-29 | 2005-05-30 | Substituted thiazoleacetic as crth2 ligands |
EA200602288A EA200602288A1 (en) | 2004-05-29 | 2005-05-30 | SUBSTITUTED TIAZOLUX ACID AS CRTH2 LIGANDS |
KR1020067027509A KR20070044404A (en) | 2004-05-29 | 2005-05-30 | Substituted thiazoleacetic as crth2 ligands |
IL179693A IL179693A0 (en) | 2004-05-29 | 2006-11-29 | Substituted thiazoleacetic as crth2 ligands |
CR8837A CR8837A (en) | 2004-05-29 | 2006-12-22 | USE OF RECEIVER LIGANDS IN THERAPY |
NO20066049A NO20066049L (en) | 2004-05-29 | 2006-12-28 | Substituted thiazole acetic acids as CRTH2 ligands |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0414194A GB0414194D0 (en) | 2004-06-24 | 2004-06-24 | Medicinal use of receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0414194D0 true GB0414194D0 (en) | 2004-07-28 |
Family
ID=32800136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0414194A Ceased GB0414194D0 (en) | 2004-05-29 | 2004-06-24 | Medicinal use of receptor ligands |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0414194D0 (en) |
-
2004
- 2004-06-24 GB GB0414194A patent/GB0414194D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL179694A0 (en) | Crth2 receptor ligands for medicinal uses | |
GB0416728D0 (en) | Medicinal use of receptor ligands | |
GB0423554D0 (en) | Therapeutic compounds | |
IL179145A0 (en) | Therapeutic compounds | |
IL179462A0 (en) | Use of the receptor gpr86 | |
GB0524428D0 (en) | Medicinal use of receptor ligands | |
GB0420424D0 (en) | Therapeutic compounds | |
EP1806147A4 (en) | Use of immunesuppressant receptor | |
HK1155670A1 (en) | Therapeutic use of anti-cs1 antibodies | |
EP1789027A4 (en) | Therapeutic use of anti-tf-antigen antibody | |
GB0424018D0 (en) | Medicinal use of receptor ligands | |
GB0412198D0 (en) | Medicinal use of receptor ligands | |
GB0414196D0 (en) | Medicinal use of receptor ligands | |
GB0414197D0 (en) | Medicinal use of receptor ligands | |
GB0424016D0 (en) | Medicinal use of receptor ligands | |
GB0425413D0 (en) | Medicinal use of receptor ligands | |
GB0424015D0 (en) | Medicinal use of receptor ligands | |
GB0414194D0 (en) | Medicinal use of receptor ligands | |
GB0414195D0 (en) | Medicinal use of receptor ligands | |
EP2016949A4 (en) | Novel use of g-protein-conjugated receptor and ligand thereof | |
GB0427138D0 (en) | Therapeutic compounds | |
EP1716865A4 (en) | Paraoxonase-containing pharmaceutical preparation | |
GB0423767D0 (en) | Therapeutic compounds | |
GB0417560D0 (en) | Therapeutic compounds | |
EP1745780A4 (en) | Medicinal preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |